Chiropractic Dosage for Lumbar Stenosis - Full Text View

Sponsor:	National University of Health Sciences
Collaborator:	Foundation for Chiropractic Education and Research
Information provided by:	National University of Health Sciences
ClinicalTrials.gov Identifier:	NCT00527527

Purpose

This randomized clinical trial pilot study will investigate the efficacy of different amounts of total treatment dosage over six weeks in 60 volunteer subjects with lumbar spinal stenosis. Subjects will be evenly randomized into four groups of either flexion distraction (FD) care or a control: Group 1 with 8 total FD treatment visits, Group 2 with 12 total FD treatment visits, Group 3 with 18 total FD treatment visits, or Group 4 with 8 total placebo control visits. The study is designed: (1) To determine the feasibility of a larger scale study in terms of logistics, recruitment efforts, and sample size estimations and (2) To determine among the three treatment groups the change in perceived pain levels and general functional health status at the end of six weeks of treatment and at three months post care as follow-up.

Condition	Intervention	Phase
Lumbar Spinal Stenosis	Procedure: flexion distraction Other: placebo control	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Chiropractic Dosage for Lumbar Stenosis

Resource links provided by NLM:

MedlinePlus related topics: Spinal Stenosis

U.S. FDA Resources

Further study details as provided by National University of Health Sciences:

Primary Outcome Measures:

Pain [ Time Frame: 6 weeks; 3 and 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Functional health status [ Time Frame: 6 weeks; 3 and 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	60
Study Start Date:	September 2007
Estimated Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Active Comparator 8 flexion distraction visits	Procedure: flexion distraction Chiropractic treatment using the flexion distraction apparatus
2: Active Comparator 12 flexion distraction visits	Procedure: flexion distraction Chiropractic treatment using the flexion distraction apparatus
3: Active Comparator 18 flexion distraction visits	Procedure: flexion distraction Chiropractic treatment using the flexion distraction apparatus
4: Placebo Comparator 8 placebo control visits	Other: placebo control Placebo for comparison with flexion distraction treatment

Eligibility

Ages Eligible for Study:	50 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Males and females at least 50 years old with lumbar spinal stenosis
Impingement of the cord and/or exiting nerve roots evidenced on spine imaging studies
Symptomatic with current pain in the back and/or one or both of the legs.
Symptoms must have been present for at least six months with an insidious onset

Exclusion Criteria:

Congenital stenosis or other spine deformities such as current spinal fractures, spinal infections, or tumors of the spine
Prior lumbar spine surgery such as laminectomy, spinal fusion, or discectomy that lacks stability or occurred within the past 3 months.
Currently pregnant or nursing
Co-morbid conditions that may preclude a person from participating in active care (laying prone on a treatment table or completing exercises) and outcome measures (Treadmill Testing, completion of questionnaires), such as severe cardiopulmonary disorders (i.e.: severe coronary artery disease, recent myocardial infarction, or vascular claudication), neuromusculoskeletal disorders (i.e.: disabling hip or knee arthritis; trochanteric bursitis; piriformis syndrome; need for assisted ambulation), or brain disorders (i.e.: dementia or Alzheimer's Disease)
Active conservative care such as physical therapy or chiropractic care for lumbar stenosis (excluding the use of oral medications or daily at-home exercises for general well-being)
Cauda equina symptoms (i.e.: perianal numbness; loss of bowel and/or bladder control)
Not fluent or literate in the English language. We will not be able to provide multiple translators within this pilot study
Current or future litigation for low back or leg pain

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00527527

Locations

United States, Illinois
National University of Health Sciences
Lombard, Illinois, United States, 60148

Sponsors and Collaborators

National University of Health Sciences

Foundation for Chiropractic Education and Research

Investigators

Principal Investigator:

Jerrilyn Cambron, DC, PhD

National University of Health Sciences

More Information

No publications provided

Responsible Party:	NUHS ( Jerrilyn Cambron, DC, PhD )
Study ID Numbers:	H0401
Study First Received:	September 8, 2007
Last Updated:	March 3, 2009
ClinicalTrials.gov Identifier:	NCT00527527 History of Changes
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Spinal Diseases
Pathological Conditions, Anatomical
Musculoskeletal Diseases

Constriction, Pathologic
Bone Diseases
Spinal Stenosis

ClinicalTrials.gov processed this record on November 09, 2009